Bristol-Myers Squibb Co (NYSE: BMY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $49.23
-
Support levelN/A
-
Resistance level$56.17
-
Beta0.3
-
RSI (14-day)16.1
- BMY is one of this month's worst performers with a return of -18.5 percent, underperforming 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- BMY is below its 200-day moving average - additional caution warranted in long positions.
- With RSI < 30, BMY is oversold. Odds slightly favor a short-term price reversal.
- Price broke below prior support level - a short-term bearish signal.
52-week low | 52-week high | Price as % of range |
---|---|---|
$39.66 | $63.11 | 46.5% |
200 day | 50 day | 20 day | 10 day |
---|---|---|---|
$53.65 | $57.30 | $55.79 | $51.84 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week9.2%
-
In the next month15.3%
-
In the next year58.3%
Period | Value |
---|---|
Historical (5 year) | 24.1% |
Last month | 24.7% |
Current estimate | 33.9% |
Next month forecast | 27.0% |